SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The MELANIA token is trending as investors grapple with a massive price collapse, with community discourse dominated by accusations of a pump-and-dump scheme linked to the Trump family. Skeptical traders are actively debating the token's near-zero value while warning others about the recurring pattern of losses associated with politically-themed meme coins.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is trending as investors digest the recent $65M public offering and the signing of a major GPU-as-a-Service contract with Hydra Host. The community is actively debating the potential for an M&A or joint venture with TSSI to scale edge AI infrastructure, alongside bullish sentiment surrounding the company's modular data center strategy and new leadership's ability to drive rapid deal flow.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

Scilex Holding Company is under intense scrutiny and market pressure following the unsealing of a lawsuit against BNY Mellon and others, which alleges a massive fraudulent scheme involving the unauthorized sale of pledged collateral shares. Investors are sharply divided, with some community members decrying the situation as another chapter in a long history of mismanagement and deceptive practices, while others express cautious optimism that the legal action signals a decisive fight against short sellers and an eventual recovery of corporate assets.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad is capturing significant attention as investors actively discuss its high-performance potential and the benefits of staking rewards while the community debates price targets and long-term ecosystem growth. Sentiment remains polarized between bullish long-term holders accumulating positions and skeptics citing concerns over supply dilution and early-stage volatility.

Direxion Shares ETF Trust - Direxion Small Cap Bear 3X ETF

Direxion Daily Small Cap Bear 3X Shares

TZA is trending as traders hedge against small-cap volatility and potential market reversals, with the community actively debating the impact of tariff uncertainty, government funding concerns, and the fundamental decay inherent in triple-leveraged inverse ETFs. While some investors view recent price action as a technical opportunity to play a market correction, others warn of the structural risks and time-decay associated with holding such instruments for the long term.

Direxion Shares ETF Trust - Direxion Small Cap Bull 3X ETF

Direxion Daily Small Cap Bull 3X Shares

TNA is trending as investors monitor increased rotation into small-cap equities, driven by persistent optimism regarding potential Federal Reserve interest rate cuts and broader economic shifts. Traders are actively discussing the index's technical performance and using the volatility of this leveraged ETF for short-term swing plays, while others are closely watching for a potential breakout to higher price levels.

Bitcoin SV (BSV) emerged following a hard fork of the Bitcoin Cash (BCH) blockchain in 2018, which had in turn forked from the BTC blockchain a year earlier. The goal of Bitcoin SV is to fulfil the original vision of the Bitcoin protocol and design as described in Satoshi Nakamoto’s white paper, early Bitcoin client software and known Satoshi writings. BSV aims to offer scalability and stability in line with the original description of Bitcoin as a peer-to-peer electronic cash system, as well as deliver a distributed data network that can support enterprise-level advanced blockchain applications. To this end, it has removed artificial block size limits and re-enabled Script commands and other technical capabilities which had been historically disabled or restricted by the protocol developers of the BTC blockchain. This allows the network to process tens of thousands of transactions per second while maintaining extremely low transaction fees for micropayments, in addition to offering advanced capabilities such as tokens, smart contracts, computation and other data use cases. The BSV network is unique in its capacity for unbounded on-chain scaling while also being more aligned with the original design of Bitcoin than any other blockchain.

Bitcoin SV

Bitcoin SV is currently generating intense community debate as participants weigh the implications of the ongoing legal proceedings surrounding Craig Wright, with bullish supporters pointing to recent scalability milestones like Teranode and the protocol's adherence to the original whitepaper. Conversely, many are dismissing the project as a fraudulent endeavor, highlighting delistings from major exchanges and a general detachment from the broader market sentiment surrounding Bitcoin.

The Allstate Corp. engages in the property and casualty insurance business and the provision of protection solutions. It operates through the following segments: Allstate Protection, Protection Services, Allstate Health and Benefits, Run-off Property-Liability, and Corporate and Other. The Allstate Protection segment offers private passenger auto, homeowners, other personal lines, and commercial insurance marketed under the Allstate, National General, and Answer Financial brand names. The Protection Services segment provides a range of solutions and services that expand and enhance customer value propositions including Allstate Protection Plans, Allstate Dealer Services, Allstate Roadside, Arity, and Allstate Identity Protection. The Allstate Health and Benefits segment focuses on voluntary benefits and individual life and health products, including life, accident, critical illness, short term disability, and other health insurance products sold through independent agents, benefit brokers, and Allstate exclusive agencies. The Run-off Property-Liability segment relates to property and casualty insurance policies with exposure to asbestos, environmental, and other claims in run-off. The Corporate and Other segment is involved in debt service, holding company activities, and certain non-insurance operations. The company was founded on April 17, 1931 and is headquartered in Northbrook, IL.

Allstate Corp (The)

Allstate Corp

Allstate is currently trending due to strong institutional interest and upward momentum, bolstered by a significant share buyback program and increased dividends that have captured investor attention. The community is actively debating the company's financial resilience in the face of rising catastrophe losses while closely monitoring its competitive positioning against other insurance leaders.

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG - ADR

Fresenius Medical Care AG & Co. KGAA

Fresenius Medical Care is capturing market attention as investors weigh a strong earnings performance against significant cost pressures and ongoing portfolio optimization efforts. While the community is actively debating the company's potential for a long-term turnaround, discussions also center on the strategic impact of new partnerships and the challenges of a difficult regulatory and inflationary environment.

Viking Holdings Ltd. provides destination-focused itineraries for curious travelers. The firm's journeys including a shore excursion in every port and an onboard and onshore enrichment program that provides deep immersion in the destination through performances of music and art, cooking demonstrations, informative port talks and carefully selected guest lecturers. It provides travel experiences through river vessels, ocean ships, expedition ships and time chartered river ship. The company was founded by Torstein Hagen in 1997 and is headquartered in Hamilton, Bermuda.

Viking Holdings Ltd.

Viking Holdings Ltd

Viking Holdings is trending as investors monitor robust demand for its luxury travel offerings, highlighted by strong quarterly earnings and high occupancy rates. While some community members remain cautious regarding broader market volatility and rising operating costs, many are bullish on the companys ability to capture affluent travel spending as it expands its fleet.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation...

Contineum Therapeutics (NASDAQ:CTNM) Price Target Raised to $20.00 at Robert W. Baird

Robert W. Baird raised their price target on shares of Contineum Therapeutics from $14.00 to $20.00 and gave the stock an "outperform" rating in a research note on Friday...

Contineum Therapeutics (NASDAQ:CTNM) Posts Earnings Results, Beats Expectations By $0.01 EPS

Contineum Therapeutics (NASDAQ:CTNM - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.49) earnings per share (EPS) for the quarter, topping the consensus...

Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones

Contineum Therapeutics to Present at the 2026 Leerink Partners Global Healthcare Conference

Beat the Market the Zacks Way: Contineum Therapeutics, Suzano, PepsiCo in Focus

Contineum Therapeutics surged 27% after a Zacks Rank upgrade, spotlighting how Zacks' strategies are beating a volatile market.

Contineum Therapeutics (CTNM) Projected to Post Earnings on Thursday

Contineum Therapeutics (NASDAQ:CTNM) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 5. (View Earnings Report at...

Contineum Therapeutics, Inc. (NASDAQ:CTNM) Given Average Rating of "Moderate Buy" by Analysts

Contineum Therapeutics, Inc. (NASDAQ:CTNM - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the seven research firms that are currently covering the firm, Marketbeat...

Contineum Therapeutics (NASDAQ:CTNM) Rating Increased to Hold at Wall Street Zen

Wall Street Zen raised shares of Contineum Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday...

Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S. Lorrain on May 9, 2017 and is headquartered in San Diego, CA.

CTNM
Contineum Therapeutics Inc. - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CTNM News

CTNMContineum Therapeutics Inc. - Ordinary Shares - Class A